Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Periodic Fevers Syndrome × secukinumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 2 Lymphoma, Follicular 2 Spondylitis, Ankylosing 1 Periodic Fevers Syndrome 1 Motor Activity 1 Melanoma 1 Crohn Disease 1 Colorectal Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

secukinumab 1 canakinumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02911857 2018-08-20

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Novartis

Phase 3 Completed

4 enrolled 7 charts

Periodic Fevers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡